Estimation of amino acid requirement adjusting for carry-over effect based on approximate change-point regression model

Biomedical Research (India)

Volumn 24, Issue 2, 2013, Pages 216-222

  Kato, Mai ^a   Hattori, Satoshi ^b   Hayamizu, Kohsuke ^c  

^a Kurume University Graduate School of Medicine Kurume University Graduate School of Medicine Graduate School Biostatistics   (Japan)

^b KURUME UNIVERSITY   (Japan)

^c NIPPON SUISAN KAISHA LTD   (Japan)

Author keywords

Indicator amino acid oxidation technique; Indispensable amino acid; Non linear mixed effect model; Wash out period

Indexed keywords

AMINO ACID;

ARTICLE; CARRY OVER EFFECT; CHANGE POINT REGRESSION MODEL; COMPUTER PROGRAM; CONTROLLED STUDY; DATA ANALYSIS; MEASUREMENT; NONLINEAR SYSTEM; NUTRITIONAL REQUIREMENT; NUTRITIONAL SCIENCE; OXIDATION; PROTEIN INTAKE; SAMPLE SIZE; SIMULATION; STATISTICAL CONCEPTS; STATISTICAL MODEL;

EID: 84875752825     PISSN: 0970938X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Zello GA, Wykes LJ, Ball RO, et al. Recent advances in methods of assessing dietary amino acid requirements for adult humans. J Nutr 1995, 125; 2907-15.
2. Roberts SA, Thorpe JM, Ball RO, et al. Tyrosine requirement of healthy men receiving a fixed phenyla-lanine intake determined by using indicator amino acid oxidation. Am J Clin Nutr 2001, 73; 276-282.
3. Kurpad R, Regan M, Vasudevan J, et al. Threonine requirements of healthy Indian men, measured by a 24-h indicator amino acid oxidation and balance technique. Am J Clin Nutr 2007, 76; 789-797.
4. Pencharz PB, Ball RO. Different approaches to define individual amino acid requirements. Annu Rev Nutr 2003, 23; 101-116.
5. WHO/FAO/UNU Expert Consultation. Protein and amino acid requirements in human nutrition. World Health Organ Tech Rep Ser 2007; 935; 1-265.
6. 13C]phenylalanine. Am J Physiol 1993, 264; E677-85.
7. Senn S, D'Angelo G, Potvin D. Carry-over in cross-over trials in bioequivalence: theoretical concerns and empirical evidence. PharmStat 2004, 3; 133-142.
8. Grieve A, Senn S. Estimating treatment effects in clinical crossover trials. J Biopharm Stat 1998, 3:191-233.
9. D'Angelo G, Potvin DTurgeon J. Crossover effects in bioequivalence studies. J Biopharm Stat 1998, 11; 35-43.
10. Seber GAF, Lee AJ. Linear regression analysis second edition. New Jersey: John Wiley and Sons Inc 2003.
11. Hall CB, Ying J, Kuo L Lipton RB. Bayesian and profile likelihood change point methods for modeling cognitive function over time. Comp Stat Data Analysis 2003, 42; 91-109.
12. Hayamizu K, Yamashita N, Hattori S, et al. A change-point regression approach for efficacy evaluation of dietary supplement. J Clin Biochem and Nutr 2009, 44; 285-290.
13. Davidian M, Giltinan D. Noninear models for repeated measurement data: An overview and update. J Agric Biol Envir Stat 2003, 8; 387-419.
14. Kriengsinyos W, Wykes LJ, Ball RO, et al. Oral and intravenous tracer protocols of the indicator amino acid oxidation method provide the same estimate of the lysine requirement in healthy men. J Nutr 2002, 132; 2251-7.
15. Slate EH, Turnbull BW. Statistical models for longitudinal biomarkers of disease onset. Stat Med 2000, 19; 617-637.
16. Mei Y, Wang L, Holte SE. A comparison of methods for determining HIV viral set point. Stat Med 2008, 27; 121-139